v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Jul. 31, 2024   152,490      
Beginning balance at Jul. 31, 2024 $ 1,274,102 $ 152 $ 2,426,819 $ (4,789) $ (1,148,080)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   332      
Issuance of common stock upon exercise of stock options 3,497   3,497    
Issuance of common stock under the employee stock purchase plan (in shares)   186      
Issuance of common stock under the employee stock purchase plan 22,344   22,344    
Vesting of restricted stock units and performance stock awards (in shares)   2,688      
Vesting of restricted stock units and performance stock awards 0 $ 4 (4)    
Stock-based compensation 507,865   507,865    
Other comprehensive (loss) income 21,031     21,031  
Net loss (23,900)       (23,900)
Ending balance (in shares) at Apr. 30, 2025   155,696      
Ending balance at Apr. 30, 2025 1,804,939 $ 156 2,960,521 16,242 (1,171,980)
Beginning balance (in shares) at Jan. 31, 2025   154,725      
Beginning balance at Jan. 31, 2025 1,607,346 $ 155 2,797,350 (22,304) (1,167,855)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   10      
Issuance of common stock upon exercise of stock options 41   41    
Vesting of restricted stock units and performance stock awards (in shares)   961      
Vesting of restricted stock units and performance stock awards 0 $ 1 (1)    
Stock-based compensation 163,131   163,131    
Other comprehensive (loss) income 38,546     38,546  
Net loss (4,125)       (4,125)
Ending balance (in shares) at Apr. 30, 2025   155,696      
Ending balance at Apr. 30, 2025 $ 1,804,939 $ 156 2,960,521 16,242 (1,171,980)
Beginning balance (in shares) at Jul. 31, 2025 158,301 158,301      
Beginning balance at Jul. 31, 2025 $ 1,799,273 $ 159 2,980,591 8,081 (1,189,558)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 27 27      
Issuance of common stock upon exercise of stock options $ 3,984   3,984    
Issuance of common stock under the employee stock purchase plan (in shares)   123      
Issuance of common stock under the employee stock purchase plan 21,506   21,506    
Vesting of restricted stock units and performance stock awards (in shares)   2,917      
Vesting of restricted stock units and performance stock awards 0 $ 3 (3)    
Issuance of common stock in connection with business acquisitions subject to future vesting (in shares)   342      
Stock-based compensation 617,441   617,441    
Other comprehensive (loss) income (15,799)     (15,799)  
Net loss $ (59,810)       (59,810)
Ending balance (in shares) at Apr. 30, 2026 161,710 161,710      
Ending balance at Apr. 30, 2026 $ 2,366,595 $ 162 3,623,519 (7,718) (1,249,368)
Beginning balance (in shares) at Jan. 31, 2026   160,570      
Beginning balance at Jan. 31, 2026 2,195,948 $ 161 3,416,085 15,187 (1,235,485)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   1      
Vesting of restricted stock units and performance stock awards (in shares)   919      
Vesting of restricted stock units and performance stock awards 0 $ 1 (1)    
Issuance of common stock in connection with business acquisitions subject to future vesting (in shares)   220      
Stock-based compensation 207,435   207,435    
Other comprehensive (loss) income (22,905)     (22,905)  
Net loss $ (13,883)       (13,883)
Ending balance (in shares) at Apr. 30, 2026 161,710 161,710      
Ending balance at Apr. 30, 2026 $ 2,366,595 $ 162 $ 3,623,519 $ (7,718) $ (1,249,368)